Monografie
The transcription factors ATF3 and EN1 as regulators of the profibrotic effects of TGF beta signaling in the pathogenesis of Systemic Sclerosis
- Sprache
-
Englisch
- Identifier
-
1125109858
Thema
GND; Hautkrankheit; Dermatologie; Hochschulschrift
Beteiligte Personen und Organisationen
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:52 MEZ
Objekttyp
- Monografie
Ähnliche Objekte (12)
The transcription factors ATF3 and EN1 as regulators of the profibrotic effects of TGF beta signaling in the pathogenesis of Systemic Sclerosis
Novel insights into the aberrant activation of fibroblasts in systemic sclerosis - Casein kinase 2, Poly(ADP-ribose)-Polymerase 1, and Janus kinase1 mediated transactivation of Janus kinase2 as novel players
Evaluation of the efficacy of the tyrosine kinase inhibitor Nintedanib and characterization of the role of the tyrosine-phosphatase SHP2 in preclinical models of Systemic Sclerosis
Tie2 as a novel key factor of microangiopathy in systemic sclerosis
Einfluss von Tocopherol auf UV-induzierte NF-κB-Regulation [NF-kappaB-Regulation] und Lipidperoxidation in HaCaT-Keratinozyten
Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Expression of the oxygen-sensitive transcription factor subunit HIF-1α in patients suffering from secondary Raynaud syndrome
Interplay of mtDNA, metabolism and microbiota in the pathogenesis of AIBD
Inhibition of Phosphodiesterase 4 (PDE4) Reduces Experimental Fibrosis by Interfering with the Release of Interleukin-6 from M2 Macrophages
Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis
Vitamin D receptor regulates TGF-β signalling in systemic sclerosis
The transcription factors ATF3 and EN1 as regulators of the profibrotic effects of TGF beta signaling in the pathogenesis of Systemic Sclerosis
Novel insights into the aberrant activation of fibroblasts in systemic sclerosis - Casein kinase 2, Poly(ADP-ribose)-Polymerase 1, and Janus kinase1 mediated transactivation of Janus kinase2 as novel players
Evaluation of the efficacy of the tyrosine kinase inhibitor Nintedanib and characterization of the role of the tyrosine-phosphatase SHP2 in preclinical models of Systemic Sclerosis
Tie2 as a novel key factor of microangiopathy in systemic sclerosis
Einfluss von Tocopherol auf UV-induzierte NF-κB-Regulation [NF-kappaB-Regulation] und Lipidperoxidation in HaCaT-Keratinozyten
Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Expression of the oxygen-sensitive transcription factor subunit HIF-1α in patients suffering from secondary Raynaud syndrome
Interplay of mtDNA, metabolism and microbiota in the pathogenesis of AIBD
Inhibition of Phosphodiesterase 4 (PDE4) Reduces Experimental Fibrosis by Interfering with the Release of Interleukin-6 from M2 Macrophages
Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis
Vitamin D receptor regulates TGF-β signalling in systemic sclerosis
The transcription factors ATF3 and EN1 as regulators of the profibrotic effects of TGF beta signaling in the pathogenesis of Systemic Sclerosis
Novel insights into the aberrant activation of fibroblasts in systemic sclerosis - Casein kinase 2, Poly(ADP-ribose)-Polymerase 1, and Janus kinase1 mediated transactivation of Janus kinase2 as novel players
Evaluation of the efficacy of the tyrosine kinase inhibitor Nintedanib and characterization of the role of the tyrosine-phosphatase SHP2 in preclinical models of Systemic Sclerosis
Tie2 as a novel key factor of microangiopathy in systemic sclerosis
Einfluss von Tocopherol auf UV-induzierte NF-κB-Regulation [NF-kappaB-Regulation] und Lipidperoxidation in HaCaT-Keratinozyten
Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Expression of the oxygen-sensitive transcription factor subunit HIF-1α in patients suffering from secondary Raynaud syndrome
Interplay of mtDNA, metabolism and microbiota in the pathogenesis of AIBD
Inhibition of Phosphodiesterase 4 (PDE4) Reduces Experimental Fibrosis by Interfering with the Release of Interleukin-6 from M2 Macrophages
Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis